The trial aimed to evaluate the safety and effectiveness of an investigational treatment added to standard antihypertensive therapy in patients with high cardiovascular risk and poorly controlled hypertension.
High Cardiovascular Risk & Hypertension
Hightower Clinical conducted a study evaluating an add-on therapy for patients with high cardiovascular risk and uncontrolled hypertension, aiming to improve blood pressure management and reduce long-term complications.
Tested New Solutions for Hard-to-Control Hypertension
Hypertension, or high blood pressure, increases the risk of heart attacks, strokes, and other cardiovascular events—especially in patients with additional risk factors. In many cases, standard medications are not enough to bring blood pressure under control. This highlights the need for innovative treatments that can provide better outcomes.
To address this challenge, Hightower Clinical conducted a clinical study evaluating the safety and efficacy of an investigational drug used alongside current antihypertensive therapies. The goal was to assess its effectiveness in improving blood pressure management in adults at high cardiovascular risk.
Current Status
Not Recruiting
Study Count
01
Frequently Asked Questions
2. Who participated in the study?
Adults with high cardiovascular risk and hypertension not adequately managed by current medications were enrolled to assess the impact of the new therapy.
3. Is this clinical trial still enrolling patients?
No, the study is currently not recruiting new participants.
Unlock New Opportunities in Clinical Research - Join Today!
We're here and eager to assist. Reach out to Hightower Clinical Research in Oklahoma City, OK for further details on how we can support you.
Get Involved Today!
© Copyright 2024 – Hightower Clinical. CREATED BY DIGITAL AUXILIUS.